Nuvig Therapeutics asegura $161M para construir un caso a favor de un enfoque mejor para las enfermedades autoinmunes.
Standard treatment for many autoimmune diseases involves using immunosuppressive drugs, which can put patients at risk of infections and other complications. Nuvig Therapeutics is working on a novel drug that could provide an alternative treatment for autoimmune diseases, with $161 million in funding to support the clinical development of its leading program. Nuvig’s approach involves … Leer más